Natamycin

This classification denotes an antifungal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8O0C852CPO. European Medicines Agency schedules Natamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09169MIG. Natamycin generally arises in the molecular formula C33H47NO13. The term NATAMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , no. 10 1971, list 11.) NATAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule natamycin under HS 29419000 and SITC 54139. As of Q4 2014, NATAMYCIN remains the US FDA Preferred Term for this commodity. Natamycin bears US NLM identifiers UMLS ID C0027444 and NCI Concept Code C47634. SMILES: O1C2(O)CC(O)C(C1CC(OC1OC(C(O)C(N)C1O)C)C=CC=CC=CC=CCC(OC(=O)C=CC1OC1CC(O)C2)C)C(=O)O.